Small molecule drug coronaviruses
The Corona pandemic showed demonstrated how vulnerabilities in health systems can have profound implications for health. Therefore, it is essential mitigating the spread and infection rate of the virus. People still suffer from severe COVID-19 symptoms despite vaccination and drug treatment opportunities are still limited. In this project, research teams of Radboud University, Protinhi Therapeutics and Artemis Bioservices (spin-offs of IMM and based in Nijmegen) jump into this gap by developing innovative small-molecule medicines against coronaviruses. These medicines will target viral proteases, enzymes crucial for the replication of the virus once entered the human body. Furthermore, the studies will offer better preparation and responsiveness towards future coronavirus epidemics.
Synthetic Organic Chemistry
Rutjes is Professor in Organic Synthesis, the research group is part of the IMM. The group designs and synthesises biologically relevant small molecules and develops new sustainable synthesis methods. The fundamentally orientated group actively seeks collaborations with business and industry. Rutjes contributes to several chemical science communities that support the exchange of (scientific) developments and ideas for application and innovation.
In the Netherlands, ZonMw plays a central role in this area as national funding organisation, coveing the entire spectrum from basic research to the implementation of new treatments, disease prevention, and health care improvements. ZonMw aims to ensure that healthy people stay that way for as long as possible, that ill people recover as quickly and completely as possible and that people who require care and nursing receive the highest standard of services. ZonMw’s principal commissioners are the Dutch Ministry of Public Health, Welfare and Sport (VWS) and the Netherlands Organisation for Scientific Research (NWO).
Want to know more?
For more information, please contact
Floris Rutjes, floris.rutjes [at] ru.nl (floris[dot]rutjes[at]ru[dot]nl)
IMM Communications: imm-communication [at] ru.nl (imm-communication[at]ru[dot]nl)